Assura Plc (LON:AGR - Get Free Report) insider Jonathan Murphy bought 393 shares of the business's stock in a transaction on Monday, January 6th. The stock was purchased at an average cost of GBX 38 ($0.47) per share, for a total transaction of £149.34 ($186.30).
Assura Stock Performance
AGR traded down GBX 0.76 ($0.01) during trading on Tuesday, hitting GBX 37.10 ($0.46). The stock had a trading volume of 7,033,453 shares, compared to its average volume of 5,112,777. The firm has a market capitalization of £1.21 billion, a P/E ratio of -3,710.00, a PEG ratio of 3.60 and a beta of 0.37. The company has a debt-to-equity ratio of 85.04, a quick ratio of 2.84 and a current ratio of 0.89. Assura Plc has a twelve month low of GBX 36.94 ($0.46) and a twelve month high of GBX 48.58 ($0.61). The company's 50-day moving average price is GBX 38.96 and its 200 day moving average price is GBX 40.51.
Assura Dividend Announcement
The firm also recently declared a dividend, which will be paid on Wednesday, January 15th. Stockholders of record on Thursday, December 12th will be issued a GBX 0.84 ($0.01) dividend. The ex-dividend date of this dividend is Thursday, December 12th. This represents a dividend yield of 2.12%. Assura's dividend payout ratio is currently -30,000.00%.
Analysts Set New Price Targets
Separately, Berenberg Bank reiterated a "buy" rating and issued a GBX 51 ($0.64) price objective on shares of Assura in a research note on Tuesday, September 17th.
Check Out Our Latest Stock Report on Assura
Assura Company Profile
(
Get Free Report)
Assura plc is a specialist healthcare property investor and developer. We enable better health outcomes through our portfolio of more than 600 healthcare buildings across the UK and Ireland, from which over six million patients are served.
We BUILD for health, having developed over 100 new healthcare buildings in our history, and at the heart of our strategy sits The Bigger Picture; Healthy Environment (E), Healthy Communities (S), Healthy Business (G).
Assura plc achieved B Corp certification in July 2024 - the first FTSE 250 business to do so.
Read More
Before you consider Assura, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Assura wasn't on the list.
While Assura currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.